BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18471033)

  • 1. Managed care and cancer outcomes for Medicare beneficiaries with disabilities.
    Roetzheim RG; Chirikos TN; Wells KJ; McCarthy EP; Ngo LH; Li D; Drews RE; Iezzoni LI
    Am J Manag Care; 2008 May; 14(5):287-96. PubMed ID: 18471033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
    Riley GF; Potosky AL; Klabunde CN; Warren JL; Ballard-Barbash R
    JAMA; 1999 Feb; 281(8):720-6. PubMed ID: 10052442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disability outcomes of older Medicare HMO enrollees and fee-for-service Medicare beneficiaries.
    Porell FW; Miltiades HB
    J Am Geriatr Soc; 2001 May; 49(5):615-31. PubMed ID: 11380756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons.
    Lee-Feldstein A; Feldstein PJ; Buchmueller T; Katterhagen G
    J Gen Intern Med; 2001 Mar; 16(3):189-99. PubMed ID: 11318915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managed care enrollment and chronically disabled women with breast cancer.
    Habermann EB; Virnig BA; Durham SB; Baxter NN
    Am J Manag Care; 2008 Aug; 14(8):514-20. PubMed ID: 18690767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
    Landrum MB; Keating NL; Lamont EB; Bozeman SR; Krasnow SH; Shulman L; Brown JR; Earle CC; Rabin M; McNeil BJ
    J Clin Oncol; 2012 Apr; 30(10):1072-9. PubMed ID: 22393093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing mortality and time until death for medicare HMO and FFS beneficiaries.
    Maciejewski ML; Dowd B; Call KT; Feldman R
    Health Serv Res; 2001 Feb; 35(6):1245-65. PubMed ID: 11221818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a change in Medicare reimbursement policy and HEDIS measures on stage at diagnosis among Medicare HMO and fee-for-service female breast cancer patients.
    Habermann EB; Virnig BA; Riley GF; Baxter NN
    Med Care; 2007 Aug; 45(8):761-6. PubMed ID: 17667310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
    McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
    JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehospitalization and survival for stroke patients in managed care and traditional Medicare plans.
    Smith MA; Frytak JR; Liou JI; Finch MD
    Med Care; 2005 Sep; 43(9):902-10. PubMed ID: 16116355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of stroke patients in Medicare fee for service and managed care.
    Retchin SM; Brown RS; Yeh SC; Chu D; Moreno L
    JAMA; 1997 Jul; 278(2):119-24. PubMed ID: 9214526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer detection and outcomes in a disability beneficiary population.
    Roetzheim RG; Chirikos TN
    J Health Care Poor Underserved; 2002 Nov; 13(4):461-76. PubMed ID: 12407963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
    Kirsner RS; Ma F; Fleming L; Federman DG; Trapido E; Duncan R; Wilkinson JD
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):769-73. PubMed ID: 16614122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disenrollment from Medicare HMOs.
    Call KT; Dowd BE; Feldman R; Lurie N; McBean MA; Maciejewski M
    Am J Manag Care; 2001 Jan; 7(1):37-51. PubMed ID: 11209449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HMOs on the inpatient utilization of medicare beneficiaries.
    Dhanani N; O'Leary JF; Keeler E; Bamezai A; Melnick G
    Health Serv Res; 2004 Oct; 39(5):1607-27. PubMed ID: 15333125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of HMOs, health insurance, and delivery systems to breast cancer outcomes.
    Lee-Feldstein A; Feldstein PJ; Buchmueller T; Katterhagen G
    Med Care; 2000 Jul; 38(7):705-18. PubMed ID: 10901354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in breast cancer treatment and survival for women with disabilities.
    McCarthy EP; Ngo LH; Roetzheim RG; Chirikos TN; Li D; Drews RE; Iezzoni LI
    Ann Intern Med; 2006 Nov; 145(9):637-45. PubMed ID: 17088576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.